Drug Shortage Report for GLUCAGEN HYPOKIT
| Report ID | 189007 |
| Drug Identification Number | 02333627 |
| Brand name | GLUCAGEN HYPOKIT |
| Common or Proper name | GLUCAGEN® HYPOKIT 1 MG |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLUCAGON |
| Strength(s) | 1MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | EA |
| ATC code | H04AA |
| ATC description | GLYCOGENOLYTIC HORMONES |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2023-04-10 |
| Actual start date | |
| Estimated end date | 2023-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-05-04 |
| Company comments | Novo Nordisk A/S is experiencing an intermittent supply shortage of GlucaGen® HypoKit that will affect delivery in Canada. The cause of the intermittent supply shortage is a shortfall in the release and supply of pre-filled syringes from an external vendor, resulting in supply constraints for GlucaGen® HypoKit. The intermittent supply shortage is not a consequence of any safety or quality-related concerns. For any questions, please contact Novo Nordisk Canada’s main distributor, Paladin Labs (1-866-340-1112 paladincs@endo.com)”. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-05-04 | English | Compare |
| v3 | 2023-04-11 | English | Compare |
| v2 | 2023-04-06 | French | Compare |
| v1 | 2023-04-06 | English | Compare |
Showing 1 to 4 of 4